Doctor profile · Federal record
Dr. Kristin Beauregard, RNP
Acute Care Nurse Practitioner (CMS: Nurse Practitioner) · Providence, RI
- NPI 1225429004
- Accepts Medicare
- 12 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
164 Summit Ave
Providence, RI 029062853
(401) 793-2500
Credentials & registration
- NPI registered
- February 2015 — 11 yrs on file
- Year of graduation
- 2014 — 12 yrs since
- Specialty taxonomy
- 363LA2100X — NUCC code
- State license (1)
- Rhode Island #APRN00009
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1225429004. Last verified May 11, 2026.Open Payments
Industry payments received
All-time total
$222
Transactions
2
Manufacturers
2
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Medtronic, INC. | 1 | $159.77 | |
| Kiniksa Pharmaceuticals International, Plc | 1 | $62.24 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
240
Patients
82
Total drug cost
$12,371
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clopidogrel (Clopidogrel Bisulfate) | Brand | 139 | 58 | $1,868 |
| Pantoprazole Sodium | Generic | 35 | 0 | $561 |
| Amoxicillin | Generic | 24 | 24 | $33 |
| Brilinta (Ticagrelor) | Brand | 22 | 0 | $9,735 |
| Atorvastatin Calcium | Generic | 20 | 0 | $174 |
Hospital affiliations
Frequently asked questions
What is Dr. Kristin Beauregard's medical specialty?
Dr. Kristin Beauregard practices Acute Care Nurse Practitioner in Providence, RI.
Where does Dr. Kristin Beauregard practice?
Dr. Kristin Beauregard practices at 164 Summit Ave, Providence, RI 029062853. Office phone: 4017932500.
What is Dr. Kristin Beauregard's NPI?
Dr. Kristin Beauregard's National Provider Identifier (NPI) is 1225429004, issued by NPPES.
Does Dr. Kristin Beauregard accept Medicare assignment?
Yes. Dr. Kristin Beauregard accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.